 | Up a level |
Ladwig, A., Suh, J., Schweitzer, F., Roeth, P., Remke, G., Warnke, C., Schroeter, M., Izquierdo-Alvarez, E., Bonmann, E., Fink, G. R., Pallasch, C. and Lehmann, H. (2020). Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis. Mult. Scler. J., 26 (3_SUPPL). S. 259 - 260. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Svacina, M. K. R., Roeth, P., Bobylev, I, Sprenger, A., Zhang, G., Sheikh, K. A. and Lehmann, H. C. (2017). CHANGES OF SERUM IGG DIMER LEVELS AFTER TREATMENT WITH IVIG IN GUILLAIN-BARRE-SYNDROME. J. Peripher. Nerv. Syst., 22 (3). S. 390 - 392. HOBOKEN: WILEY. ISSN 1529-8027